On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
From Automation to Inflexion: AI’s Historical Trajectory in Pharma The pharmaceutical industry began its journey with […]
Japan represents one of the world’s most demanding pharmaceutical markets, with rigorous quality standards that go […]
Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biotechnology, offering transformative therapeutic solutions […]
The rise of Cell and Gene Therapies (CGT) marks a significant advancement in modern medicine, offering […]
Seminar date: May 16, 2024 Thanks to its size, technological advancements, and commitment to innovation, […]
Japan presents a unique landscape for pharmaceutical companies, both domestic and international. The recent study published […]